Myeloid Angiogenic Cells Act as Alternative M2 Macrophages and Modulate Angiogenesis through Interleukin-8

Endothelial progenitor cells (EPCs) promote angiogenesis, and clinical trials have shown such cell therapy to be feasible for treating ischemic disease. However, clinical outcomes have been contradictory owing to the diverse range of EPC types used. We recently characterized two EPC subtypes, and id...

詳細記述

保存先:
書誌詳細
主要な著者: Medina, Reinhold J, O’Neill, Christina L, O’Doherty, T Michelle, Knott, Henry, Guduric-Fuchs, Jasenka, Gardiner, Tom A, Stitt, Alan W
フォーマット: Artigo
言語:Inglês
出版事項: ScholarOne 2011
主題:
Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3188859/
https://ncbi.nlm.nih.gov/pubmed/21670847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2011.00129
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料